This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mozdzanowska, K. Articles by Gerhard, W. Search for Related Content PubMed PubMed Citation Articles by Mozdzanowska, K. Articles by Gerhard, W.

 Previous Article  |  Next Article 

J. Virol., Jun 1997, 4347-4355, Vol 71, No. 6
Copyright © 1997, American Society for Microbiology

A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro

K Mozdzanowska, M Furchner, G Washko, J Mozdzanowski and W Gerhard
The Wistar Institute, Philadelphia, Pennsylvania 19104-4268, USA.

We have previously shown that a pulmonary influenza virus infection in SCID mice can be cured by treatment with monoclonal antibodies (MAbs) specific for the viral transmembrane protein hemagglutinin (HA) but not for matrix 2. Since both types of MAbs react with infected cells but only the former neutralizes the virus, it appeared that passive MAbs cured by neutralization of progeny virus rather than reaction with infected host cells. To prove this, we selected a set of four HA- specific MAbs, all of the immunoglobulin G2a isotype, which reacted well with native HA expressed on infected cells yet differed greatly (>10,000-fold) in virus neutralization (VN) activity in vitro, apparently because of differences in antibody avidity and accessibility of the respective determinants on the HA of mature virions. Since the VN activities of these MAbs in vitro were differentially enhanced by serum components, we determined their prophylactic activities in vivo and used them as measures of their actual VN activities in vivo. The comparison of therapeutic and prophylactic activities indicated that these MAbs cured the infection to a greater extent by VN activity (which was greatly enhanced in vivo) and to a lesser extent by reaction with infected host cells. Neither complement- nor NK cell-dependent mechanisms were involved in the MAb-mediated virus clearance.

This article has been cited by other articles:

• Nguyen, H. H., Zemlin, M., Ivanov, I. I., Andrasi, J., Zemlin, C., Vu, H. L., Schelonka, R., Schroeder, H. W. Jr., Mestecky, J. (2007). Heterosubtypic Immunity to Influenza A Virus Infection Requires a Properly Diversified Antibody Repertoire. J. Virol. 81: 9331-9338 [Abstract] [Full Text]  
• Wang, S., Taaffe, J., Parker, C., Solorzano, A., Cao, H., Garcia-Sastre, A., Lu, S. (2006). Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines. J. Virol. 80: 11628-11637 [Abstract] [Full Text]  
• Luke, T. C., Kilbane, E. M., Jackson, J. L., Hoffman, S. L. (2006). Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?. ANN INTERN MED 145: 599-609 [Abstract] [Full Text]  
• Huber, V. C., McKeon, R. M., Brackin, M. N., Miller, L. A., Keating, R., Brown, S. A., Makarova, N., Perez, D. R., MacDonald, G. H., McCullers, J. A. (2006). Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza.. CVI 13: 981-990 [Abstract] [Full Text]  
• Thomas, P. G., Brown, S. A., Yue, W., So, J., Webby, R. J., Doherty, P. C. (2006). An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses. Proc. Natl. Acad. Sci. USA 103: 2764-2769 [Abstract] [Full Text]  
• Mozdzanowska, K., Furchner, M., Zharikova, D., Feng, J., Gerhard, W. (2005). Roles of CD4+ T-Cell-Independent and -Dependent Antibody Responses in the Control of Influenza Virus Infection: Evidence for Noncognate CD4+ T-Cell Activities That Enhance the Therapeutic Activity of Antiviral Antibodies. J. Virol. 79: 5943-5951 [Abstract] [Full Text]  
• Jeon, S. H., Kayhan, B., Ben-Yedidia, T., Arnon, R. (2004). A DNA Aptamer Prevents Influenza Infection by Blocking the Receptor Binding Region of the Viral Hemagglutinin. J. Biol. Chem. 279: 48410-48419 [Abstract] [Full Text]  
• Tumpey, T. M., Garcia-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Basler, C. F. (2004). Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 101: 3166-3171 [Abstract] [Full Text]  
• Mozdzanowska, K., Feng, J., Gerhard, W. (2003). Virus-Neutralizing Activity Mediated by the Fab Fragment of a Hemagglutinin-Specific Antibody Is Sufficient for the Resolution of Influenza Virus Infection in SCID Mice. J. Virol. 77: 8322-8328 [Abstract] [Full Text]  
• Henrickson, K. J. (2003). Parainfluenza Viruses. Clin. Microbiol. Rev. 16: 242-264 [Abstract] [Full Text]  
• Feng, J. Q., Mozdzanowska, K., Gerhard, W. (2002). Complement Component C1q Enhances the Biological Activity of Influenza Virus Hemagglutinin-Specific Antibodies Depending on Their Fine Antigen Specificity and Heavy-Chain Isotype. J. Virol. 76: 1369-1378 [Abstract] [Full Text]  
• Reed, A. J., Riley, M. P., Caton, A. J. (2000). Virus-induced Maturation and Activation of Autoreactive Memory B Cells. J. Exp. Med. 192: 1763-1774 [Abstract] [Full Text]  
• Riberdy, J. M., Christensen, J. P., Branum, K., Doherty, P. C. (2000). Diminished Primary and Secondary Influenza Virus-Specific CD8+ T-Cell Responses in CD4-Depleted Ig-/- Mice. J. Virol. 74: 9762-9765 [Abstract] [Full Text]  
• Kalinke, U., Oxenius, A., Lopez-Macias, C., Zinkernagel, R. M., Hengartner, H. (2000). Virus neutralization by germ-line vs. hypermutated antibodies. Proc. Natl. Acad. Sci. USA 97: 10126-10131 [Abstract] [Full Text]  
• Ourmanov, I., Bilska, M., Hirsch, V. M., Montefiori, D. C. (2000). Recombinant Modified Vaccinia Virus Ankara Expressing the Surface gp120 of Simian Immunodeficiency Virus (SIV) Primes for a Rapid Neutralizing Antibody Response to SIV Infection in Macaques. J. Virol. 74: 2960-2965 [Abstract] [Full Text]  
• Lin, M. T., Hinton, D. R., Marten, N. W., Bergmann, C. C., Stohlman, S. A. (1999). Antibody Prevents Virus Reactivation Within the Central Nervous System. J. Immunol. 162: 7358-7368 [Abstract] [Full Text]  
• Yasui, H., Kiyoshima, J., Hori, T., Shida, K. (1999). Protection against Influenza Virus Infection of Mice Fed Bifidobacterium breve YIT4064. CVI 6: 186-192 [Abstract] [Full Text]  
• Topham, D. J., Doherty, P. C. (1998). Longitudinal Analysis of the Acute Sendai Virus-Specific CD4+ T Cell Response and Memory. J. Immunol. 161: 4530-4535 [Abstract] [Full Text]  
• Topham, D. J., Doherty, P. C. (1998). Clearance of an Influenza A Virus by CD4+ T Cells Is Inefficient in the Absence of B Cells. J. Virol. 72: 882-885 [Abstract] [Full Text]